Join
Live feed
·
INSIDERFilingvia Quantisnow
Carisma Therapeutics Inc. logo

Chief Scientific Officer Klichinsky Michael sold $124,343 worth of shares (484,347 units at $0.26), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CARM· Carisma Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CARM (Carisma Therapeutics Inc.) and more on Quantisnow.